Free Trial
OTCMKTS:NVZMY

Novozymes A/S (NVZMY) Stock Price, News & Analysis

Novozymes A/S logo
$56.61 +0.61 (+1.09%)
(As of 12/20/2024 05:55 PM ET)

About Novozymes A/S Stock (OTCMKTS:NVZMY)

Key Stats

Today's Range
$56.23
$56.83
50-Day Range
$55.30
$68.45
52-Week Range
$49.99
$72.50
Volume
22,933 shs
Average Volume
13,062 shs
Market Capitalization
$26.51 billion
P/E Ratio
35.83
Dividend Yield
1.17%
Price Target
N/A
Consensus Rating
Buy

Company Overview

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

Novozymes A/S Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
58th Percentile Overall Score

NVZMY MarketRank™: 

Novozymes A/S scored higher than 58% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Novozymes A/S are expected to grow by 17.58% in the coming year, from $1.82 to $2.14 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Novozymes A/S is 35.83, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 115.15.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Novozymes A/S is 35.83, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 111.98.

  • Price to Earnings Growth Ratio

    Novozymes A/S has a PEG Ratio of 3.87. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Novozymes A/S has a P/B Ratio of 12.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.00% of the outstanding shares of Novozymes A/S have been sold short.
  • Short Interest Ratio / Days to Cover

    Novozymes A/S has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Novozymes A/S has recently increased by 150.00%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Novozymes A/S pays a meaningful dividend of 1.14%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Novozymes A/S does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Novozymes A/S is 41.77%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Novozymes A/S will have a dividend payout ratio of 30.84% next year. This indicates that Novozymes A/S will be able to sustain or increase its dividend.

  • Read more about Novozymes A/S's dividend.
  • Percentage of Shares Shorted

    0.00% of the outstanding shares of Novozymes A/S have been sold short.
  • Short Interest Ratio / Days to Cover

    Novozymes A/S has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Novozymes A/S has recently increased by 150.00%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Novozymes A/S has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Basic Materials companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Novozymes A/S this week, compared to 0 articles on an average week.
Receive NVZMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

NVZMY Stock News Headlines

Novonesis added to European Conviction List at Goldman Sachs
Novonesis Reports Strong Q3 Growth in 2024
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share
The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.
What Wall Street expects from Novozymes A-S (B)'s earnings
Novozymes A-S (B) Un earnings: here's what to expect
Novozymes A/S B (NSISb)
Novozymes A/S (NSISBC.XC)
See More Headlines

NVZMY Stock Analysis - Frequently Asked Questions

Novozymes A/S's stock was trading at $54.9050 on January 1st, 2024. Since then, NVZMY shares have increased by 3.1% and is now trading at $56.61.
View the best growth stocks for 2024 here
.

Novozymes A/S (OTCMKTS:NVZMY) issued its quarterly earnings results on Wednesday, January, 31st. The biotechnology company reported $0.36 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.47 by $0.11. The biotechnology company earned $664.46 million during the quarter.

Novozymes A/S subsidiaries include these companies: PrecisionBiotics Group Limited, OrganoBalance GmbH, Pacific Vet Group-USA, Allopartis, TJ Technologies, Iogen Bio-Products, Natural Industries, and more.

Shares of NVZMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Last Earnings
1/31/2024
Today
12/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
OTCMKTS:NVZMY
Employees
6,756
Year Founded
2000

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.60 billion
Cash Flow
$0.78 per share
Book Value
$4.45 per share

Miscellaneous

Free Float
N/A
Market Cap
$26.51 billion
Optionable
Not Optionable
Beta
0.87

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

This page (OTCMKTS:NVZMY) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners